IT Will Be Cornerstone In Personalizing Medicine, Siemens Says
This article was originally published in The Gray Sheet
Executive Summary
Siemens has established itself as a leader in both imaging and in vitro diagnostics with the aid of recent multibillion-dollar acquisitions, but the company's ability to leverage its IT expertise will be critical to tie the pieces together, the firm says
You may also be interested in...
Siemens Claims Top IVD Slot With $7 Billion Dade Behring Purchase
Siemens' medical unit solidified its status July 25 as the only company offering a comprehensive suite of both imaging and in vitro diagnostic products with its $7 billion acquisition of Dade Behring
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.
The Aspirin Test For AI?
US FDA Commissioner Robert Califf tells Congress that regulators don’t have to know how artificial intelligence works in medicine, but must make very sure it actually does work.